Company (NYSE: SMG) insider plans 50,000-share Rule 144 sale

Rhea-AI Filing Summary

A shareholder of a NYSE-listed company has filed a notice of proposed sale under Rule 144 for 50,000 shares of common stock. The filing lists an aggregate market value of $3,319,937.60 for these shares, based on the disclosure in the form.

The shares are to be sold through Merrill, 8890 Lyra Drive, 5th Floor, Columbus, OH 43240, with an approximate sale date of February 12, 2026 on the NYSE. The form notes that there were 58,039,753 shares outstanding of this class at the time of the notice.

The seller originally acquired the 50,000 common shares on June 16, 1995 via a partnership contribution from Community Fund & General Partnership, with payment made on the same date. The signer represents they are not aware of any undisclosed material adverse information about the issuer’s current or prospective operations.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Merrill 8890 Lyra Drive 5th Flr Columbus OH 43240	50000	3319937.6	58039753	02/12/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	06/16/1995	Partnership contribution	Community Fund & General Partnership			50000	06/16/1995	NA

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does this Form 144 filing for SMG indicate?

This Form 144 indicates a shareholder’s intent to sell 50,000 common shares of a NYSE-listed issuer under Rule 144. It discloses the planned sale amount, value, timing, broker, and how and when the shares were originally acquired.

How many SMG shares are planned to be sold and what is their value?

The filing reports a planned sale of 50,000 common shares with an aggregate market value of $3,319,937.60. This amount reflects the market value referenced in the notice for the proposed Rule 144 sale through the designated broker.

When were the SMG shares being sold under Rule 144 originally acquired?

The 50,000 common shares were acquired on June 16, 1995 through a partnership contribution from Community Fund & General Partnership. The filing shows the acquisition date and notes payment was made on the same date as the contribution.

When is the planned sale date for the 50,000 SMG shares?

The notice lists an approximate sale date of February 12, 2026 for the 50,000 common shares. This date reflects when the shareholder expects to execute trades on the NYSE through the broker identified in the filing.

Which broker is handling the proposed SMG share sale disclosed in Form 144?

The proposed sale is to be handled by Merrill, located at 8890 Lyra Drive, 5th Floor, Columbus, OH 43240. This broker and address are specifically identified in the section describing the class of securities to be sold.

How many SMG common shares were outstanding at the time of this notice?

The filing states that 58,039,753 common shares were outstanding for this class at the time of the notice. This figure provides context for the size of the planned 50,000-share sale relative to the issuer’s total outstanding shares.

What representation does the seller make about SMG’s information in this Form 144?

The seller represents that they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed. This representation is a standard attestation included in the Form 144 notice language.